Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: A role beyond M235T?

Hypertension

Volumn 51, Issue 3, 2008, Pages 778-783

  Pereira, Tiago Veiga ^a   Nunes, Ane C F ^a   Rudnicki, Martina ^a   Yamada, Yoshiji ^b   Pereira, Alexandre Costa ^a   Krieger, José E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MIE UNIVERSITY   (Japan)

Author keywords

Angiotensinogen; Hypertension; M235T; Meta analysis; Polymorphism; T174M

Indexed keywords

ANGIOTENSINOGEN;

ALLELE; ARTICLE; ASIAN; CELL HETEROGENEITY; CONFIDENCE INTERVAL; ESSENTIAL HYPERTENSION; EUROPE; EXON; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MEDICAL LITERATURE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

ALLELES; ANGIOTENSINOGEN; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 39749113160     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.100370     Document Type: Article

References (56)

1. Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension. 2006;48:14-20.
2. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev. 1997;18:662-677.
3. Pereira AC, Mota GF, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE. Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes. Hypertension. 2003;41:25-30.
4. Lanz JR +-/74, Pereira AC, Lemos PA, Martinez E, Krieger JE. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta. 2005;362:176-181.
5. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymo/rphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003;23:1269-1275.
6. Pettiti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. New York, NY: Oxford University Press; 1994.
7. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
8. Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE. Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis. Am Heart J. 2007;153:821-830.
9. Pereira TV, Rudnicki M, Cheung BMY, Baum L, Yamada Y, Oliveira PSL, Pereira AC, Krieger JE. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens. 2007;25:1763-1774.
10. Rothstein H, Sutton A, Borenstein M. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. Chichester, United Kingdom: Wiley; 2005.
11. Marco J, Zabay JM, Garcia-Marco MA, Gomez G, Mulet JM, Munar MA, Soler J, Viader C. Polimorfismo T174M del gen del angiotensinógeno: relaciones opuestas con la hipertensión arterial esencial y con la obesidad en una población homogénea de Mallorca (Islas Baleares). Nefrologia. 2005;25:629-636.
12. Vasku A, Soucek M, Tschoplova S, Stejskalova A. An association of BMI with A(-6)G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension. J Hum Hypertens. 2002;16:427-430.
13. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, Tichet J, Mallet C, Poirier O, Plouin PF, Cambien F. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. J Hypertens. 1998;16:37-44.
14. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens. 1995;13:311-317.
15. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, Nystrom F, Hagg A, Lind L. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens. 2002;20:657-663.
16. Kurland L, Melhus H, Sarabi M, Millgard J, Ljunghall S, Lind L. Polymorphisms in the renin-angiotensin system and endothelium-dependent vasodilation in normotensive subjects. Clin Physiol. 2001;21:343-349.
17. Barbalic M, Skaric-Juric T, Cambien F, Barbaux S, Poirier O, Turek S, Vrhovski-Hebrang D, Cubrilo-Turek M, Rudan I, Rudan P, Narancic NS. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Am J Hypertens. 2006;19:837-842.
18. Fernandez-Llama P, Poch E, Oriola J, Botey A, Rivera F, Revert L. Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage. Am J Hypertens. 1998;11:439-444.
19. Lesage S, Velho G, Vionnet N, Chatelain N, Demenais F, Passa P, Soubrier F, Froguel P. Genetic studies of the renin-angiotensin system in arterial hypertension associated with non-insulin-dependent diabetes mellitus. J Hypertens. 1997;15:601-606.
20. Liu Y, Jin W, Jiang ZW, Zhang KX, Sheng HH, Jin L, Sheng YY, Huang W, Yu JD. Relationship between six single nucleotide polymorphisms of angiotensinogen gene and essential hypertension [in Chinese]. Chin J Med Genet. 2004;21:116-119.
21. Wang JH, Lin CM, Wang LS, Lai NS, Chen DY, Cherng JM. Association between molecular variants of the angiotensinogen gene and hypertension in Amis tribes of eastern Taiwan. J Formos Med Assoc. 2002;101:183-188.
22. Suwazono Y, Kobayashi E, Sakurada I, Ohkubo Y, Nogawa K, Kido T. Associations of the angiotensinogen gene (M235T, T174M) and the angiotensin I-converting enzyme gene (I/D) with blood pressure in Japanese workers. Blood Press. 1999;8:23-28.
23. Sato N, Katsuya T, Nakagawa T, Ishikawa K, Fu Y, Asai T, Fukuda M, Suzuki F, Nakamura Y, Higaki J, Ogihara T. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci. 2000;68:259-272.
24. Tsai CT, Fallin D, Chiang FT, Hwang JJ, Lai LP, Hsu KL, Tseng CD, Liau CS, Tseng YZ. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension. 2003;41:9-15.
25. Iso H, Harada S, Shimamoto T, Sato S, Kitamura A, Sankai T, Tanigawa T, Iida M, Komachi Y. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens. 2000;18:1197-1206.
26. Iwai N, Ohmichi N, Nakamura Y, Mitsunami K, Kinishita M. Molecular variants of the angiotensinogen gene and hypertension in a Japanese population. Hypertens Res. 1994;17:117-121.
27. Yi-Yang Z, Xiao J, Hai-hui S, Gang L, Yun-lin C, Jun H. Association between partial indexes of angiotensinogen gene polymorphisms and the risk of essential hypertension: a community case-control study. Chin J Clin Rehabil. 2006;10:208-212.
28. Morise T, Takeuchi Y, Takeda R. Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med. 1995;237:175-180.
29. Williams SM, Ritchie MD, Phillips JA, III, Dawson E, Prince M, Dzhura E, Willis A, Semenya A, Summar M, White BC, Addy JH, Kpodonu J, Wong LJ, Felder RA, Jose PA, Moore JH. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered. 2004;57:28-38.
30. Nair KG, Shalia KK, Ashavaid TF, Dalal JJ. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal. 2003;17:141-146.
31. Frossard PM, Hill SH, Elshahat YI, Obineche EN, Bokhari AM, Lestringant GG, John A, Abdulle AM. Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population. Clin Genet. 1998;54:285-293.
32. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation. 1994;90:2207-2212.
33. Mustafina OE, Nasibullin TR, Khusnutdinova EK. Association of the T174M polymorphism of the angiotensinogen gene with essential hypertension in Russians and Tatars from Bashkortostan. Mol Biol (Mosk). 2002;36:599-604.
34. Agachan B, Isbir T, Yilmaz H, Akoglu E. Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med. 2003;35:545-549.
35. Chistyakov DA, Turakulov RI, Moiseev VS, Nosikov VV. Association between polymorphism T174M of the angiotensinogen gene and arterial hypertension in muscovites. Molecular Biology. 1999;33:521-523.
36. Wang WY, Glenn CL, Zhang W, Benjafield AV, Nyholt DR, Morris BJ. Exclusion of angiotensinogen gene in molecular basis of human hypertension: sibpair linkage and association analyses in Australian anglocaucasians. Am J Med Genet. 1999;87:53-60.
37. Velez DR, Guruju M, Vinukonda G, Prater A, Kumar A, Williams SM. Angiotensinogen promoter sequence variants in essential hypertension. Am J Hypertens. 2006;19:1278-1285.
38. Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, Felder RA. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem. 2002;48:2131-2140.
39. Rodriguez-Perez JC, Rodriguez-Esparragon FJ, Hernandez-Perera O, Fiuza-Perez MD, nabitarte-Prieto A, Losada-Cabrera A. Effects of the angiotensinogen gene M235T and A(-6)G variants on blood pressure and other vascular risk factors in a Spanish population. J Hum Hypertens. 2000;14:789-793.
40. Giner V, Corella D, Chaves FJ, Pascual JM, Portoles O, Marin P, Lozano JV, Armengod ME, Redon J. Polimorfismos genéticos del sistema reninaangiotensina e hipertensión arterial esencial en la población española. Med Clin (Barc). 2001;117:525-529.
41. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, Walker WG, Whelton PK, Williams RR. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension. 1998;32:393-401.
42. Li NF, Zhou L, Wu WD, Shi Y, Wang XL, Wang J, Li HJ, Zhang DL, Zu H, Ouyang WJ, Bu KL, Zhou KM, Cheng QY, Guli N, Zhu DH. The relationship between the variants in 5′ upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang [in Chinese]. Chin J Med Genet. 2004;21:23-28.
43. Liu Y, Qin W, Hou S, Shan G, Zhuo M, Chen Y, Cui C, Caidan L, Qiu C. A-6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations. Hypertens Res. 2001;24:159-163.
44. Kong XD, Yang YX, Zhang SZ. Haplotypes extending across AGT are associated essential hypertension [in Chinese]. Hereditas (Beijing). 2004;26:797-802.
45. Wu SJ, Chiang FT, Chen WJ, Liu PH, Hsu KL, Hwang JJ, Lai LP, Lin JL, Tseng CD, Tseng YZ. Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis. Physiol Genomics. 2004;17:79-86.
46. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens. 1999;17:757-763.
47. Qin J, Liu Z, Wu D, Zhu N, Zhou X, Fung Y, Lin B. Genotyping the -6A/G functional polymorphism in the core promoter region of angiotensinogen gene by microchip electrophoresis. Electrophoresis. 2005;26:219-224.
48. Aitkhozhina NA, Liudvikova EK. Polymorphism of the promotor region of the angiotensinogen gene and the gene for angiotensin I-converting enzyme in arterial hypertension and myocardial ischemia of the Kazakh ethnic groups. Russ J Genet. 2003;39:293-299.
49. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension. 2000;35:1297-1300.
50. Aristizábal D, García E, McEwen J, Caulfield M, Méndez J, Medina E, Zapata N, Correa M. Bases genéticas de la hipertensión arterial esencial en Colombia: avances en nueve años de estudio. Rev Colomb Cardiol. 2006;12:409-430.
51. Hegele RA, Harris SB, Hanley AJ, Sun F, Connelly PW, Zinman B. -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. J Hum Genet. 1998;43:37-41.
52. Kong X, Zhang S, Yang Y, Zheng K, Tong Y, Shi J, Zhang K, Su Z, Cheng W. The relationship between haplotypes of angiotensinogen gene and essential hypertension [in Chinese]. Chin J Med Genet. 2002;19:488-490.
53. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, Yabana M, Watanabe Y, Sumida Y, Nagahara T, Ochiai H, Ishii M. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension. 1997;30:1325-1330.
54. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD, Ott J, Kumar A. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem. 2002;277:36889-36896.
55. Dickson ME, Zimmerman MB, Rahmouni K, Sigmund CD. The -20 and -217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells. Hypertension. 2007;49:631-639.
56. Martinez E, Puras A, Escribano J, Sanchis C, Carrion L, Artigao M, Divison JA, Masso J, Fernandez JA. Threonines at position 174 and 235 of the angiotensinogen polypeptide chain are related to familial history of hypertension in a Spanish-Mediterranean population. Br J Biomed Sci. 2002;59:95-100.